Mirina Closes Series A-1 Financing to Support miRNA Drug Development

While the amount of the funding was not disclosed, an official from the investment firm that founded Mirina said that it is sufficient to fund the company's operations for 12 to 15 months.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories